Effectiveness of the Use of Antidepressants in the Treatment of Muscle Type Temporomandibular Disorders

Trial Information
Status: Not yet recruiting
Location: See location...
Intervention Type: Drug, Device
Study Type: Interventional
Study Phase: Phase 2/Phase 3

The aim of this study is evaluate the effectiveness of the use of antidepressants in the treatment of muscle type temporomandibular disorders, with a sample of 60 to 80 participants.

Am I eligible for this trial?
Participation Requirements
Minimum Age:
Healthy Volunteers:

• Patients treated at the Centro Hospitalar e Universitário de Coimbra (CHUC);

• Patients who, according to the diagnostic Criteria for Temporomandibular disorder (DC/TMD) , present Myofascial pain in the masticatory muscles for more than 6 months;

• Adult patients

Where is this trial taking place?
Other Locations
CHUC - Centro Hospitalar e Universitário de Coimbra
Who do I contact about this trial?
Bruno M Sousa
When is this trial taking place?
Start Date: March 2021
Estimated Completion Date: May 2021
How many participants will be in this trial?
Target number of participants: 80
What treatment is being studied in this trial?
Active Comparator: Citalopram
Citalopram 10mg
Active Comparator: Amitriptyline
Amitritptyline 25 mg
Active Comparator: Bite Splint
Michigan Splint, nocturnal use
Who are the authors of this trial?
Bruno M Sousa

This content was sourced from clinicaltrials.gov